AN INTRANASAL VACCINE TO AID IN PREVENTION OF FELINE INFECTIOUS PERITONITIS (FIP) CAUSED BY FIP VIRUS.
FELOCELL FIP is for intranasal (IN) vaccination of healthy cats 16 weeks of age or older as an aid in preventing feline infectious peritonitis (FIP) caused by feline infectious peritonitis virus (FIPV). FELOCELL FIP contains an attenuated, temperature-sensitive (TS) strain of FIP virus propagated on an established feline cell line. The vaccine is freeze-dried to preserve stability.
IMPORTANT NOTICE!
Please note that this is a general product information according to US approvals, for specific regulatory information concerning your market please contact Regulatory department email: Regulatory.AffairsMER@zoetis.com
Cats vaccinated intranasally (IN) with FELOCELL FIP develop a protective immune response and do not become hypersensitized. This practical benefit may be attributed to the temperature-sensitive FELOCELL FIP vaccine strain, which replicates in the upper respiratory tract but does not spread systemically at 39°C, the cat’s body temperature.
1. General Directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Mix well. Use dropper to inoculate entire volume into nasal passages (1/2 volume into each nasal passage). Cats may sneeze or shake their heads at the time of administration.
2. Primary Vaccination: Healthy cats 16 weeks of age or older should receive 2 IN doses administered 3-4 weeks apart.
3. Revaccination: Annual revaccination with a single dose is recommended.
Store at 2°-7°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze.
Use entire contents when first opened.
Burn containers and all unused contents.
Droppers should be used to administer this vaccine.
As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
